These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18756326)

  • 1. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C; Romaniuk PJ
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
    Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
    Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
    Morrison AA; Venables JP; Dellaire G; Ladomery MR
    Biochem Cell Biol; 2006 Oct; 84(5):789-98. PubMed ID: 17167543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
    Kohsaka T; Tagawa M; Takekoshi Y; Yanagisawa H; Tadokoro K; Yamada M
    Hum Mutat; 1999; 14(6):466-70. PubMed ID: 10571943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG
    Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
    Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
    Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
    Nurmemmedov E; Yengo RK; Uysal H; Karlsson R; Thunnissen MM
    Biophys Chem; 2009 Dec; 145(2-3):116-25. PubMed ID: 19853363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis.
    Denamur E; Bocquet N; Baudouin V; Da Silva F; Veitia R; Peuchmaur M; Elion J; Gubler MC; Fellous M; Niaudet P; Loirat C
    Kidney Int; 2000 May; 57(5):1868-72. PubMed ID: 10792605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
    Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.
    Bruening W; Bardeesy N; Silverman BL; Cohn RA; Machin GA; Aronson AJ; Housman D; Pelletier J
    Nat Genet; 1992 May; 1(2):144-8. PubMed ID: 1302008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.
    Li H; Hou S; Hao T; Azam S; Liu C; Shi L; Lei H
    RNA Biol; 2015; 12(12):1364-71. PubMed ID: 26512748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone acetyltransferase p300 promotes the activation of human WT1 promoter and intronic enhancer.
    Shao Y; Lu J; Zhang G; Liu C; Huang B
    Arch Biochem Biophys; 2005 Apr; 436(1):62-8. PubMed ID: 15752709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.
    Bor YC; Swartz J; Morrison A; Rekosh D; Ladomery M; Hammarskjöld ML
    Genes Dev; 2006 Jun; 20(12):1597-608. PubMed ID: 16738405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
    Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
    J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.